Sunday, Jul 03, 2022 | Last Update : 05:38 AM IST

glenmark pharmaceuticals

Glenmark's Favipiravir shows positive results in Phase-3 COVID-19 trial

The results also demonstrated 40 per cent faster achievement of 'clinical cure' defined as the physician's assessment of normalization

23 Jul 2020 9:40 AM

India's Glenmark to test potential covid19 drug combination

Glenmark is already conducting clinical trials in India of just favipiravir as a potential treatment for COVID-19

26 May 2020 12:28 PM

ADVERTISEMENT
ADVERTISEMENT